key: cord-0934153-vwgbgd1c authors: Roffman, Joshua L.; Dunn, Erin C. title: Neuropsychopharmacology reviews 2022 hot topics: the prenatal environment and risk for mental illness in young people date: 2021-08-18 journal: Neuropsychopharmacology DOI: 10.1038/s41386-021-01143-x sha: 510414d9d3318b340b302c901e8f7bea2f7985a1 doc_id: 934153 cord_uid: vwgbgd1c nan (ABCD) Study data, we assessed cumulative effects of adverse prenatal exposures on psychopathology at ages 9-10 [1] . Each adversity associated independently with modest effects on psychopathology scores. However, when linearly combined, risk for clinically significant symptoms risk rose sharply (7% for no exposures vs. 29% for ≥4 exposures, OR 3.53, Fig. 1 ). More systematic, fully prospective efforts to characterize the prenatal "exposome" may account for even greater proportions of risk. Maternal infections during pregnancy also augment psychopathology risk in offspring. However, relatively few pathogens (e.g., TORCH, Zika virus) associated with poor neurodevelopmental outcomes cross the placenta. Further, the severity of maternal infection does not necessarily predict the degree of risk to the fetus, as demonstrated in a recent Swedish birth registry study where even uncomplicated maternal urinary tract infections predicted a 1.3-fold increase in depression, and 1.9-fold increase in autism in the offspring [2] . These and other findings have implicated the maternal immune responseelements of which do cross into the fetal circulationas a more proximal culprit than the pathogens themselves. Accordingly, lack of routine vertical transmission of SARS-CoV-2, the virus that causes COVID-19, does not alleviate concerns that it may predispose to subtle fetal brain injury. Such concerns are potentially compounded in the setting of (1) increased frequency of neonatal complications following maternal SARS-CoV-2 infection [3] , and (2) pandemic-related social stressors, which themselves likely confer risk in utero, if these too combine linearly. Importantly, recognition of fetal life's importance to subsequent mental illness risk has also catalyzed efforts to discover protective, and potentially preventative, interventions during pregnancy. For example, large, prospective studies have consistently associated periconceptional folic acid intake with~50% reduction in autism riskincluding among children at increased genetic risk [4] . Our work has also related increased prenatal folic acid exposure to neuroprotective effects on cortical development that persist through adolescence [5] . Efforts to identify additional modifiable factors in the prenatal environment that mitigate risk are ongoing, including through the planned NIH HEALthy Brain and Child Development Study which will study~7500 children from the second trimester of pregnancy through the first decade of life. These efforts may also provide greater temporal specificity, as effects of both risk-conferring and protective exposures likely vary by gestational stage. In parallel, efforts to develop objective, non-invasive markers to document prenatal environment risks, including the study of primary teeth [6] , may ultimately enhance personalized risk assessment, and herald more sophisticated and effective early interventions. Association of adverse prenatal exposure burden with child psychopathology in the Adolescent Brain Cognitive Development (ABCD) Study Long-term Risk of Neuropsychiatric Disease After Exposure to Infection In Utero Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection: The INTERCOVID Multinational Cohort Study Association of maternal prenatal vitamin use with risk for autism spectrum disorder recurrence in young siblings Association of prenatal exposure to population-wide folic acid fortification with altered cerebral cortex maturation in youths Teeth as potential new tools to measure early-life adversity and subsequent mental health risk: an interdisciplinary review and conceptual model AUTHOR CONTRIBUTIONS JLR and ECD contributed equally to the writing and editing of the manuscript. FUNDING Supported by the Mass General Early Brain Development Initiative (JLR, ECD), R01MH120402 (JLR), R01MH113930 (ECD) The authors declare no competing interests. Correspondence and requests for materials should be addressed to J.L.R. Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.